Education
About Us
Working with TipRanks
Follow Us
Changmao Biochemical Engineering Co. Ltd. Class H (HK:0954)
:0954
0954 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.26 - HK$0.61
Previous CloseN/A
Volume624.00K
Average Volume (3M)270.80K
Market Cap
HK$150.96M
Enterprise ValueHK$707.69M
Total Cash (Recent Filing)¥89.55M
Total Debt (Recent Filing)¥494.64M
Price to Earnings (P/E)―
Beta0.15
Next Earnings
Aug 15, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 22, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding183,700,000
10 Day Avg. Volume32,400
30 Day Avg. Volume270,800
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Changmao Biochemical Engineering Co. Ltd. Class H News
PremiumCompany Announcements
Changmao Biochemical Engineering Announces AGM and Key Resolutions
PremiumCompany Announcements
Changmao Biochemical Announces Director Resignations Due to RetirementPremiumCompany Announcements
Changmao Biochemical Announces Board Changes to Drive Future Growth
PremiumCompany Announcements
Changmao Biochemical Reports Decreased Revenue and Losses for 2024
PremiumCompany Announcements
Changmao Biochemical Faces Loss Despite Revenue Rise
PremiumCompany Announcements
Changmao Biochemical Set for Key Board Meeting
PremiumCompany Announcements
Changmao Biochemical Announces H1 2024 Profit Warning---
0954 FAQ
What was Changmao Biochemical Engineering Co. Ltd. Class H’s price range in the past 12 months?
Changmao Biochemical Engineering Co. Ltd. Class H lowest stock price was HK$0.26 and its highest was HK$0.61 in the past 12 months.
What is Changmao Biochemical Engineering Co. Ltd. Class H’s market cap?
Changmao Biochemical Engineering Co. Ltd. Class H’s market cap is HK$150.96M.
When is Changmao Biochemical Engineering Co. Ltd. Class H’s upcoming earnings report date?
Changmao Biochemical Engineering Co. Ltd. Class H’s upcoming earnings report date is Aug 15, 2025 which is in 111 days.
How were Changmao Biochemical Engineering Co. Ltd. Class H’s earnings last quarter?
Changmao Biochemical Engineering Co. Ltd. Class H released its earnings results on Mar 28, 2025. The company reported -HK$0.101 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.101.
Is Changmao Biochemical Engineering Co. Ltd. Class H overvalued?
According to Wall Street analysts Changmao Biochemical Engineering Co. Ltd. Class H’s price is currently Overvalued.
Does Changmao Biochemical Engineering Co. Ltd. Class H pay dividends?
Changmao Biochemical Engineering Co. Ltd. Class H pays a Notavailable dividend of HK$0.086 which represents an annual dividend yield of N/A. See more information on Changmao Biochemical Engineering Co. Ltd. Class H dividends here
What is Changmao Biochemical Engineering Co. Ltd. Class H’s EPS estimate?
Changmao Biochemical Engineering Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Changmao Biochemical Engineering Co. Ltd. Class H have?
Changmao Biochemical Engineering Co. Ltd. Class H has 183,700,000 shares outstanding.
What happened to Changmao Biochemical Engineering Co. Ltd. Class H’s price movement after its last earnings report?
Changmao Biochemical Engineering Co. Ltd. Class H reported an EPS of -HK$0.101 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.614%.
Which hedge fund is a major shareholder of Changmao Biochemical Engineering Co. Ltd. Class H?
Currently, no hedge funds are holding shares in HK:0954
---
Company Description
Changmao Biochemical Engineering Co. Ltd. Class H
Changmao Biochemical Engineering Co Ltd is a organic acid producer in the PRC. The company produces organic acids products for sales to food additive, chemical and pharmaceutical industries. Its products are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid and aspartame. These products are used as food additives or medical inter-mediaries. Its products are produced along vertical production chains. Its geographic locations include Mainland China, Europe includes the Great Britain, Germany, Turkey, Spain and Italy, Asia Pacific includes Hong Kong, Indonesia, Australia, India, Thailand and Japan, America, Others.
---
Technical Analysis
Bank of Communications Co
―
Shanghai Fosun Pharmaceutical (Group) Co
―
Zijin Mining Group Co
―
Shanghai Pharmaceuticals Holding Co
―
CSPC Pharmaceutical Group
―
---